| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000044838 |
| Receipt No. | R000051216 |
| Scientific Title | The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome. |
| Date of disclosure of the study information | 2021/07/13 |
| Last modified on | 2021/08/11 (Ver. 3) |
| Basic information | ||
| Public title | The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome. | |
| Acronym | The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome. | |
| Scientific Title | The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome. | |
| Scientific Title:Acronym | The investigation of safety and efficacy of oocyte cryopreservation for two cases of Turner's syndrome. | |
| Region |
|
|
| Condition | ||
| Condition | Turner's syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the safety and efficacy of oocyte cryopreservation for Tuner's girl. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The numbers of retrieved oocyte |
| Key secondary outcomes | complication |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Turner syndrome has been demonstrated by chromosomal testing, there is hope for fertility preservation, and it is psychologically accepted. | |||
| Key exclusion criteria | If the patients not have the consent of primary doctor, if the patients do not have the consent of herself or her family, or if it is judged that the patients cannot tolerate this treatment both physically and mentally. | |||
| Target sample size | 2 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | St. Marianna University School of Medicine | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 216-8511 | ||||||
| Address | 2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa | ||||||
| TEL | 044-977-8111 | ||||||
| nao@marianna-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | St. Marianna University School of Medicine | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 216-8511 | ||||||
| Address | 2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa | ||||||
| TEL | 044-977-8111 | ||||||
| Homepage URL | |||||||
| s2takae@marianna-u.ac.jp | |||||||
| Sponsor | |
| Institute | St. Marianna University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | N/A |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | St. Marianna University School of Medicine |
| Address | 2-16-1 Sugao, Miyamae-ku, Kawasaki city, Kanagawa |
| Tel | 044-977-8111 |
| k-sienbu.mail@marianna-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | After IRB permission, the clinical study has started on thin August. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051216 |